Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Antibodies have clearly demonstrated their utility as therapeutics, providing highly selective
and effective drugs to treat diseases in oncology, hematology, cardiology, immunology and …

Colorectal cancer (CRC) is presently the third deadliest cancer in the world. This malignant
cancer usually precedes the progression of precancerous lesions, and it is challenging to …

Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

In this study, we cover the convergence of radiochemistry for imaging and therapy with
advances in nanoparticle (NP) design for biomedical applications. We first explore NP …

The Mesenchymal Epithelial Transition (MET) receptor tyrosine kinase is upregulated or
mutated in 5% of non-small-cell lung cancer (NSCLC) patients and overexpressed in …

Overexpression and/or mutations of the receptor tyrosine kinase (RTK) subfamilies, such as
epidermal growth factor receptors (EGFR) and vascular endothelial growth factor receptors …

In vivo imaging is influenced by the half-life, tissue penetration, biodistribution, and affinity of
the imaging probe. Immunoglobulin G (IgG) is composed of discrete domains with known …

Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate
and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is …

Colorectal cancer (CRC), a highly heterogeneous genetic disease, is currently the second
leading cause of cancer-related deaths worldwide. This malignant cancer is typically …